BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 16088440)

  • 1. The role of corticosteroids in chronic obstructive pulmonary disease.
    Calverley PM
    Semin Respir Crit Care Med; 2005 Apr; 26(2):235-45. PubMed ID: 16088440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM; White CM; Coleman CI
    Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of corticosteroids on lung function in asthma and chronic obstructive pulmonary disease.
    Donohue JF; Ohar JA
    Proc Am Thorac Soc; 2004; 1(3):152-60. PubMed ID: 16113428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease.
    Calverley PM
    Proc Am Thorac Soc; 2004; 1(3):161-6. PubMed ID: 16113429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of bronchodilators in chronic obstructive pulmonary disease.
    Weder MM; Donohue JF
    Semin Respir Crit Care Med; 2005 Apr; 26(2):221-34. PubMed ID: 16088439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids in chronic obstructive pulmonary disease: a review.
    Telenga ED; Kerstjens HA; Postma DS; Ten Hacken NH; van den Berge M
    Expert Opin Pharmacother; 2010 Feb; 11(3):405-21. PubMed ID: 20102305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing treatment of chronic obstructive pulmonary disease: an assessment of current therapies.
    Wise RA; Tashkin DP
    Am J Med; 2007 Aug; 120(8 Suppl 1):S4-13. PubMed ID: 17678942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Friend or foe: combination therapy with inhaled corticosteroids and long-acting beta2-agonists in chronic obstructive pulmonary disease (COPD)].
    Gillissen A; Gessner C; Hoheisel G; Juergens U
    Pneumologie; 2008 Jul; 62(7):430-7. PubMed ID: 18398787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease.
    Pujades-Rodríguez M; Smith CJ; Hubbard RB
    QJM; 2007 Aug; 100(8):509-17. PubMed ID: 17609226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future.
    Chung KF; Caramori G; Adcock IM
    Eur J Clin Pharmacol; 2009 Sep; 65(9):853-71. PubMed ID: 19557399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid therapy in chronic obstructive pulmonary disease.
    OBrien A; Ward NS
    Med Health R I; 2002 Feb; 85(2):52-5. PubMed ID: 11881166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The place of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Selroos O
    Curr Med Res Opin; 2004 Oct; 20(10):1579-93. PubMed ID: 15462691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Jones PW
    Proc Am Thorac Soc; 2004; 1(3):167-70. PubMed ID: 16113430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
    Balkissoon R; Make B
    COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival with tiotropium compared to long-acting Beta-2-agonists in Chronic Obstructive Pulmonary Disease.
    Gershon AS; Wang L; To T; Luo J; Upshur RE
    COPD; 2008 Aug; 5(4):229-34. PubMed ID: 18671148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
    Kim WJ; Sheen SS; Kim TH; Huh JW; Lee JH; Kim EK; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Oh YM; Lee SD
    Respirology; 2009 Mar; 14(2):260-3. PubMed ID: 19210659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
    Tashkin DP
    Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhaled corticosteroids for COPD].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Jul; 147(29):1398-404. PubMed ID: 12894463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.